<i>IDH1/2</i> mutations in acute myeloid leukemia.

导出 LinkOut

翻译打印收藏纠错

作者： Ja Min,Byun ^[1] ; Seung-Joo,Yoo ^[2] ; Hyeong-Joon,Kim ^[1] ; Jae-Sook,Ahn ^[2] ; Youngil,Koh ^[3] ; Jun Ho,Jang ^[3] ; Sung-Soo,Yoon ^[1]

作者单位： Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea. ^[1] Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. ^[2] Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Korea. ^[3] Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. ^[4]

关键词 Acute myeloid leukemia Biomarker Drug target IDH Korean

DOI 10.5045/br.2021.2021152

PMID 35197370

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Blood research

2022年57卷1期

13-19页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

<i>IDH1/2</i> mutations in acute myeloid leukemia.

Blood research

相似文献

Blood research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

<i>IDH1/2</i> mutations in acute myeloid leukemia.

Blood research

相似文献

Blood research

相关期刊

检索历史清除